Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients.
2021
In this study we evaluated the potential of expanded NK cells (eNKs) from two sources combined with the mAbs daratumumab and pembrolizumab to target primary multiple myeloma (MM) cells ex vivo. In ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
52
References
2
Citations
NaN
KQI